The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome
Abstract
To determine whether cerebrospinal fluid (CSF) viral burden measurements can assist in the evaluation of human immunodeficiency virus (HIV)‐associated neurocognitive disorders, we quantified HIV type 1 (HIV‐1) RNA in CSF. Because previous findings suggested that disease stage, lymphocytic pleocytosis, and HIV‐1 RNA levels in plasma may influence CSF viral burden, these variables were examined as potential modifying factors. HIV‐1 RNA levels were quantified by using a reverse transcriptase–polymerase chain reaction assay. Performance on a comprehensive neuropsychological (NP) battery was noted in 97 prospectively enrolled, HIV‐infected subjects. Among subjects with acquired immunodeficiency syndrome (AIDS) (<200 CD 4 lymphocytes), NP impairment was associated with significantly higher CSF RNA levels (3.1 vs 1.8 log 10 copies/ml; p = 0.02); most impaired subjects met criteria for HIV‐associated dementia or minor cognitive–motor disorder. In subjects without AIDS, CSF RNA and NP impairment were unrelated. Before AIDS, CSF RNA was strongly correlated to plasma RNA and to pleocytosis, but in AIDS, CSF and plasma RNA were independent. In conclusion, we found elevated CSF HIV‐1 RNA levels in NP impaired subjects with AIDS. Before AIDS, systemic viral replication, possibly through CD 4+ mononuclear cell trafficking, may govern virus levels in CSF, whereas in AIDS, CD4 cell depletion may unmask a correlation between increased productive central nervous system HIV infection and clinical neurocognitive disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ho, D. D., Rota, T. R., Schooley, R. T., Kaplan, J. C., Allan, J. D., Groopman, J. E., Resnick, L., Felsenstein, D., Andrews, C. A., & Hirsch, M. S. (1985) · New England Journal of Medicine · doi:10.1056/nejm198512123132401 · Cited by 1,102
Quantitation of HIV-1 RNA in Plasma Predicts Outcome after Seroconversion
Mellors, J. W., Kingsley, L. A., Rinaldo, C. R., Todd, J. A., Hoo, B. S., Kokka, R. P., & Gupta, P. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-122-8-199504150-00003 · Cited by 917
Host factors and the pathogenesis of HIV-induced disease
Fauci, A. S. (1996) · Nature · doi:10.1038/384529a0 · Cited by 829
Report of a Working Group of the American Academy of Neurology AIDS Task Force (1991) · Neurology · doi:10.1212/wnl.41.6.778 · Cited by 768
Changes in Plasma HIV-1 RNA and CD4+ Lymphocyte Counts and the Risk of Progression to AIDS
O'Brien, W. A., Hartigan, P. M., Martin, D., Esinhart, J., Hill, A., Benoit, S., Rubin, M., Simberkoff, M. S., & Hamilton, J. D. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602153340703 · Cited by 720
The HNRC 500-Neuropsychology of Hiv infection at different disease stages
Heaton, R. K., Grant, I., Butters, N., White, D. A., Kirson, D., Atkinson, J. H., McCutchan, J. A., Taylor, M. J., Kelly, M. D., Ellis, R. J., et al. (1995) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617700000230 · Cited by 631
Self-citationMulder, J., McKinney, N., Christopherson, C., Sninsky, J., Greenfield, L., & Kwok, S. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.2.292-300.1994 · Cited by 558
Katzenstein, D. A., Hammer, S. M., Hughes, M. D., Gundacker, H., Jackson, J. B., Fiscus, S., Rasheed, S., Elbeik, T., Reichman, R., Japour, A., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610103351502 · Cited by 477
Reiber, H., & Felgenhauer, K. (1987) · Clinica Chimica Acta · doi:10.1016/0009-8981(87)90250-6 · Cited by 461
Early penetration of the blood‐brain‐barrier by HIV
Resnick, L., Berger, J. R., Shapshak, P., & Tourtellotte, W. W. (1988) · Neurology · doi:10.1212/wnl.38.1.9 · Cited by 445
Cited by
Heaton, R. K., Clifford, D. B., Franklin, D. R., Woods, S. P., Ake, C., Vaida, F., Ellis, R. J., Letendre, S. L., Marcotte, T. D., Atkinson, J. H., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e318200d727 · Cited by 2,353
Self-citationGroups, F. T. C. A. H., Heaton, R. K., Franklin, D. R., Ellis, R. J., McCutchan, J. A., Letendre, S. L., LeBlanc, S., Corkran, S. H., Duarte, N. A., Clifford, D. B., et al. (2011) · Journal of NeuroVirology · doi:10.1007/s13365-010-0006-1 · Cited by 1,533
Self-citationHIV-associated neurocognitive disorder — pathogenesis and prospects for treatment
Saylor, D., Dickens, A. M., Sacktor, N., Haughey, N., Slusher, B., Pletnikov, M., Mankowski, J. L., Brown, A., Volsky, D. J., & McArthur, J. C. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.27 · Cited by 1,036
HIV-associated cognitive impairment before and after the advent of combination therapy
Sacktor, N., McDermott, M. P., Marder, K., Schifitto, G., Selnes, O. A., McArthur, J. C., Stern, Y., Albert, S., Palumbo, D., Kieburtz, K., et al. (2002) · Journal of Neurovirology · doi:10.1080/13550280290049615 · Cited by 584
HIV dementia: an evolving disease
McArthur, J. C. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.08.042 · Cited by 462
Metadata
- Authors
- Ellis, R. J., Hsia, K., Spector, S. A., Nelson, J. A., Heaton, R. K., Wallace, M. R., Abramson, I., Atkinson, J. H., Grant, I., & McCutchan, J. A.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 1997-11
- Volume
- 42
- Issue
- 5
- Pages
- 679-688
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2029097526
- Cited by
- 321
- References
- 22
- FWCI
- 5.31
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. https://app.cochat.ai/papers/10.1002/ana.410420503
- The paper
- Ellis, R. J., Hsia, K., Spector, S. A., Nelson, J. A., Heaton, R. K., Wallace, M. R., Abramson, I., Atkinson, J. H., Grant, I., & McCutchan, J. A. (1997). Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. Annals of Neurology. https://doi.org/10.1002/ana.410420503
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.